Cortical Activity During Vojta Stimulation in Healthy Adults

February 5, 2021 updated by: Josue Fernandez Carnero

Cortical Activity During Sensorial Tactile Stimulation in Healthy Adults. The Innate Patron Activation With Vojta Therapy.

The present study is focused on the importance of sensory stimuli at the tactile and proprioceptive level that occur during the activation of the pectoral area, following the treatment protocol of Vojta Therapy (VT), and which are the areas that are activated in the central nervous system (CNS) during stimulation, as well as muscle activity. For the activation record it will be used electroencephalography and electromyography electrods.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The relationship between intrinsic and extrinsic factors condition the development of the human being. The sensory organs are the main recipients of the information, thanks to them we are able to interact with the environment and register the influence of the stimuli inside the organism. The brain receives information from the environment through its senses.

At the tactile level the brain receives afferent information thanks to the activation of mechanoreceptors of the skin during interaction with the environment. The receivers encode the stimulus information and send it to the specific CNS structures. In these structures, the sensations received are combined and the stimulus is transformed into a perfectly elaborated response, both in a conscious and innate way.

Dr. Vojta showed in 1974 the locomotion reflects the result of the study of motor ontogenesis. This discovery was the demonstration of the existence of innate and preprogrammed motor patterns in Humans.

Most of the studies related to VT have showed the improvements obtained by the patients, validating it as a method of treatment and evidencing objective changes after its application. This research aim to go further and verify that cortical areas are activated during the application of an external and proprioceptive stimuli that are performed during the first phase of VT turning and which areas are responsible for producing and organizing the efferent response.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
    • Madrid
      • Alcorcón, Madrid, Spain, 28922
        • Roberto Cano de la Cuerda

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy adult population with no history of neurological disease or others that may affect the test.
  • Age between 18 and 50 years.
  • Not having addiction to alcohol or drugs at the time of the study.
  • Not knowing the basics of Vojta Therapy, or knowing the responses of stimuli when applying therapy.
  • Not having the pharmacological treatment that affects the functioning of the Central Nervous System and may interfere with the test results.

Exclusion Criteria:

  • Those who do not meet the inclusion criteria
  • Not having suffered ms-skeletal alterations in the last 6 months.
  • Known sensory abnormalities.
  • Diagnosis of some neurological pathology or condition that could alter the study such as pain, radiculopathy.
  • Refuse to sign the informed consent.
  • Claustrophobia.

  • Those that can spoil the magnetic resonance image.

    • Be a carrier of some metallic material.
    • Pregnancy or nursing mother.

  • The contraindications of Vojta Therapy.

    • Acute diseases that present with fever and / or inflammation.
    • Vaccination with live germs, according to medical criteria (usually 10 days after vaccination).
    • In case of crystal bone disease, uncontrolled heart disease.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: Vojta group
All participants were properly instructed and signed an informed consent previous to the interventions. They were comfortably laid down on their back with eyes open, wearing the EEG cap and electromyography electrodes during the intervention. They were asked to remain relaxed and still during the whole process. After a first minute of resting, the experimental group received a continuous reflex locomotion stimulus during the next 8 minutes.
Other: Vojta
Reflex locomotion stimulus
SHAM_COMPARATOR: Control group
On the contrary, the control group received a continuous sham stimulus during the next 8 minutes.
Other: Sham
sham stimulus

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Electroencephalography (EEG)
Time Frame: 10 minutes per patient
EEG power in alpha and beta bands
10 minutes per patient
Electromyography (EMG)
Time Frame: 10 minutes per patient
EMG power in Rectus abdominis, wrist extensors and tibialis anterior
10 minutes per patient

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Josue Fernandez Carnero

Collaborators

Universidad Europea de Madrid

Investigators

  • Principal Investigator: Ismael Sanz, PhD, UEM

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 8, 2020

Primary Completion (ACTUAL)

March 1, 2020

Study Completion (ACTUAL)

March 15, 2020

Study Registration Dates

First Submitted

February 28, 2020

First Submitted That Met QC Criteria

March 19, 2020

First Posted (ACTUAL)

March 23, 2020

Study Record Updates

Last Update Posted (ACTUAL)

February 10, 2021

Last Update Submitted That Met QC Criteria

February 5, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • UEMURJC

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Brain

Clinical Trials on Vojta

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe